MedPath

Long-term Nutritional Intervention Study to Determine How Protein Affects Calcium Metabolism

Phase 1
Completed
Conditions
Osteoporosis
Interventions
Other: Low protein diet
Registration Number
NCT00671944
Lead Sponsor
Yale University
Brief Summary

Osteoporosis is a major health problem in men and women in this country and the incidence of this disease is rising. We think that environmental factors such as nutrition may play a role in the increasing prevalence of osteoporosis. In particular, we think that a diet that is too low in protein may be contributing to bone loss. The primary purpose of this study is to compare the long-term impact of a low protein diet on measures of bone and calcium metabolism.

Detailed Description

The protocol is composed of a 9.5-week study, consisting of a 3-week adjustment period followed by a 6.5-week experimental period. During the adjustment period, subjects consume a well-balanced lead-in diet designed to stabilize baseline Ca homeostasis. In the subsequent experimental period, subjects will consume the experimental diet containing 0.7 g protein/kg, 800-1200 mg phosphorus, 800 mg calcium and 2300 mg sodium. During days -6 to -1 of the adjustment diet, 5-10 and days 40-45 of the experimental period, we will measure Ca absorption and kinetics. Weekly assessments of Ca homeostasis will be done using our standard measures of calcitropic hormones, markers of bone turnover, and urine and serum minerals.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
11
Inclusion Criteria
  • Healthy Asian or Caucasian women between the ages of 20-40 years.
Exclusion Criteria
  • Diseases or medical conditions: gastrointestinal diseases, osteoporosis, diabetes, hypertension, liver disease, thyroid disorders, kidney disease, kidney stones, cancer, heart disease, eating disorders, obesity, hypogonadism , amenorrhea, oligomenorrhea, abnormal serum FSH or estradiol levels, birth control medication, or other hormone-altering medications, pregnancy.
  • Lifestyle: smoking, excessive exercise (although moderate exercise is allowed), prescription medications known to influence vitamin D or calcium metabolism or gastric acid, excessive body weight change during the past 6 months, food allergies, unusual eating habits, or medically prescribed diets.
  • Also excluded are prisoners and individuals who are cognitively impaired.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Low protein dietLow protein diet
Primary Outcome Measures
NameTimeMethod
Calcium absorption and kineticsBaseline, day 5 and week 6
Secondary Outcome Measures
NameTimeMethod
Serum Parathyroid hormonebaseline and weekly
Markers of bone turnoverbaseline and weekly

Trial Locations

Locations (1)

Yale New Haven Hospital Research Unit

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath